The abundances of immune cells, which delivered pro-tumor suppression (including macrophages, myeloid-derived suppressor cells (MDSCs), and regulatory T cells), were positively associated with CD86 expressions in patients with BC. This evidence concerns the gene CD86 and neoplasm.